Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-057604
Date:2019-11-19
Issuer: CRISPR THERAPEUTICS AG (CRSP)
Original Submission Date:

Reporting Person:

NOVAK RODGER
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON SHARES 2019-11-19 M 33,618 a $14.43 33,618 direct
COMMON SHARES 2019-11-19 S 33,618 d $70.00 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 14.43 2019-11-19 deemed execution date M 33,618 (d) 2024-01-15 common shares 33,618 $14.43 236,382 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 270,000 options to purchase common shares were granted on june 15, 2017 and originally vested in 48 equal monthly installments commencing upon the grant date. pursuant to dr. novak's amended and restated employment agreement with the company, subject to his continued employment, beginning november 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule.
WhaleWisdom Logo

Elevate your investments